Clinical Trial: A Study of LY3985863 in Healthy Participants
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Participant- and Investigator-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneou
Brief Summary:
The purpose of this study is to evaluate how well LY3985863 is tolerated and what side effects may occur in healthy Chinese participants.The study drug will be administered subcutaneously (SC) (under the skin).Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.
Read more